Skip to main content

Immuneering Corp

IMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001790340

No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Immuneering Corp changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of IMRX: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders51159+9
Shares11.9M11.2K9.59M−2.27M (−19.1%)
Value$34.3M$32.3K$12.3M−$22.0M (−64.2%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Immuneering Corp at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to IMRX in Q2 2024
InstitutionSharesValue% of portfolio
Prosight Management, LP550,000$704.0K0.21%
Marshall Wace, LLP384,075$491.6K0.00%
Renaissance Technologies LLC349,100$446.8K0.00%
Two Sigma Advisers, LP248,700$318.3K0.00%
Two Sigma Investments, LP210,025$268.8K0.00%
Susquehanna International Group, LLP88,756$113.6K0.00%
Y-Intercept (Hong Kong) Ltd59,960$76.7K0.00%
Acadian Asset Management LLC53,445$67.0K0.00%
Centiva Capital, LP45,811$58.6K0.00%
HighTower Advisors, LLC43,960$57.0K0.00%
Point72 Asia (Singapore) Pte. Ltd.34,609$44.3K0.01%
Squarepoint Ops LLC24,262$31.1K0.00%
HRT Financial LP21,364$27.0K0.00%
Paloma Partners Management Co18,203$23.3K0.00%
Ground Swell Capital, LLC11,806$15.1K0.01%
Mirae Asset Global ETFs Holdings Ltd.11,389$14.6K0.00%
Qube Research & Technologies Ltd10,813$13.8K0.00%
Russell Investments Group, Ltd.6,594$8.44K0.00%
Cubist Systematic Strategies, LLC5,850$7.49K0.00%
Catalyst Funds Management Pty Ltd5,600$7.17K0.00%
Point72 (DIFC) Ltd4,983$6.38K0.00%
Federated Hermes, Inc.4,509$5.77K0.00%
Nordwand Advisors, LLC2,000$2.56K0.00%
Macquarie Group Ltd1,136$1.45K0.00%
EverSource Wealth Advisors, LLC345$3900.00%
Farther Finance Advisors, LLC80$940.00%
Nisa Investment Advisors, LLC10$130.00%
Capital Advisors, Ltd. LLC39$00.00%

Sold out (19)

Institutions that held Immuneering Corp at the end of Q1 2024 and filed for Q2 2024 without it.

Not filed for Q2 2024 yet (1)

Institutions that held Immuneering Corp at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IMRX in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Oracle Alpha Inc.11,165$32.3K